Clinical trials
Active, not recruiting Lymphoma, B-Cell trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2017 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 7 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 16 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Loxo Oncology, Inc. | 4 |
| Janssen Research & Development, LLC | 2 |
| Regeneron Pharmaceuticals | 2 |
| Acerta Pharma BV | 1 |
| AstraZeneca | 1 |
| Caribou Biosciences, Inc. | 1 |
| Celgene | 1 |
| Genmab | 1 |
| Kite, A Gilead Company | 1 |
| Peter MacCallum Cancer Centre, Australia | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, B-Cell | 16 |
| Lymphoma, Non-Hodgkin | 10 |
| Lymphoma, Large B-Cell, Diffuse | 5 |
| Hematologic Diseases | 4 |
| Lymphoma | 4 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 3 |
| Lymphoma, Follicular | 2 |
| Lymphoma, Mantle-Cell | 2 |
| Neoplasms | 2 |
| Recurrence | 2 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.